Immediate Impact
55 standout
Citing Papers
Management of patients with advanced-stage HER2-positive breast cancer: current evidence and future perspectives
2024 Standout
A Basic Review on Estrogen Receptor Signaling Pathways in Breast Cancer
2023 Standout
Works of Christopher Chow being referenced
Neoadjuvant palbociclib on ER+ breast cancer (N007): clinical response and EndoPredict’s value
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Christopher Chow | 65 | 209 | 83 | 192 | 97 | 23 | 490 | |
| Darin R. Goldman | 42 | 233 | 6 | 167 | 193 | 20 | 485 | |
| H Steiner | 86 | 120 | 27 | 189 | 79 | 31 | 574 | |
| Stephan M. Stockberger | 215 | 45 | 82 | 96 | 254 | 18 | 523 | |
| Hikmet Hasıripi | 18 | 373 | 14 | 278 | 21 | 26 | 480 | |
| José Luis Bueno | 35 | 92 | 25 | 96 | 15 | 24 | 443 | |
| Jan Erik Freund | 162 | 24 | 36 | 107 | 217 | 29 | 503 | |
| Mohamed Kurer | 44 | 15 | 94 | 55 | 207 | 28 | 450 | |
| Audrey Looi | 18 | 119 | 56 | 35 | 148 | 32 | 447 | |
| Jeremy Markowitz | 236 | 158 | 126 | 68 | 59 | 23 | 494 | |
| C. N. Nair | 98 | 69 | 117 | 20 | 71 | 40 | 478 |
All Works
Login with ORCID to disown or claim papers
Loading papers...